Atlas Trials

Clinical Study on the Application of 18F-HER2 Affibody PET Imaging in HER2-Expressing Breast Cancer

Clinical trial NCT06916637 · RECRUITING

Trial details

NCT number
NCT06916637
Sponsor
The Affiliated Hospital of Qingdao University
Status
RECRUITING
Study type
OBSERVATIONAL
Breast CancerBreast Cancer, HER2-Expression
Start date
2025-04-09
Primary completion
2027-12-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.